Skip to main content
. 2023 Sep 22;7:e2300037. doi: 10.1200/PO.23.00037

FIG 2.

FIG 2.

Effects of chr8 gain on OS. (A) Fusion status and risk stratification are significant for OS. (B) Gains in chr8 are associated with improved OS in fusion-negative cases. (C) No statistically significant association with gains in chr8 in fusion-positive cases. (D) OS similar regardless of the presence or absence of RAS pathway gene mutation. Chr, chromosome; FN, fusion-negative; FP, fusion-positive; OS, overall survival; RMS, rhabdomyosarcoma.